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MinireviewRNA Targets
of the Fragile X Protein
severe form of mental retardation, consisted of an iso-
leucine to asparagine at position 304 in the second KH
domain of FMRP (DeBoulle et al., 1993; Siomi et al.,
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1994). This mutation further highlighted the importanceUniversity of Minnesota
of the putative RNA binding activity of FMRP and itsBox 206, University of Minnesota Health Center
role in mental function. FMRP was found to have RNAMinneapolis, Minnesota 55455
binding activity in vitro by virtue of its ability to bind
homopolymers of poly(rG) and poly(rU). However, the in
vitro RNA binding activity of FMRP is likely to be com-Three papers published recently in Cell bring the
plex. Deletion analyses indicate that only the first KHpower of human genetics, Drosophila genetics, and
domain binds RNA, and the I304N mutation in the sec-genomics to bear on the understanding of fragile X
ond KH domain does not alter the RNA binding activitysyndrome. They provide further support for the impor-
of FMRP. The N-terminal region of FMRP, with no knowntance of local protein synthesis within a neuron as a
RNA binding motif, also binds poly(rG). It has been dem-determinant of proper synaptogenesis and the devel-
onstrated that FMRP can bind to mRNAs from brain,opment of cognitive abilities.
including its own mRNA (Brown et al., 1998). Importantly,
the in vivo RNA targets of FMRP remain to be deter-Fragile X syndrome (FRAXA) is a common form of inher-
mined.ited mental retardation that occurs with a frequency of
FMRP and the Ribosome1 in 4,000 males and 1 in 8,000 females. FRAXA is inher-
The subcellular distribution of FMRP provided furtherited as an X-linked dominant disease with reduced pene-
clues regarding its function. FMRP is found predomi-trance; 80% of males and 30% of females carrying a
nantly in the cytoplasm. However, this protein has bothmutant allele of the fragile X mental retardation-1 (FMR1)
a functional nuclear localization signal (NLS) within itsgene exhibit an abnormal phenotype. Fragile X patients
N terminus and a nuclear export signal (NES) at the Ctypically present with mental retardation, with an IQ be-
terminus (Eberhart et al., 1996). The presence of thesetween 20 and 60. Neurological symptoms can also con-
two motifs raised the possibility that FMRP shuttles be-sist of hyperactivity, attention deficit disorder, and autis-
tween the cytoplasm and the nucleus, perhaps in thetic-like behaviors. In addition, the clinical picture of
transport of RNA from the nucleus to the cytoplasm. Infragile X includes the abnormal facial features of a promi-
the cytoplasm, FMRP associates with polyribosomesnent jaw and large ears. Post-pubescent males have
that are actively translating protein. This associationenlarged testicles.
is RNA-dependent via mRNP particles. Other proteinsCloning of FMR1 revealed a novel mutational mecha-
found within the FMRP-mRNP complex include the frag-nism—the expansion of an unstable trinucleotide repeat.
ile-X-related FXR1P and FXR2P, each of which also hasThe FMR1 unstable repeat is a CGG trinucleotide lo-
potential RNA binding sites. Nucleolin, a known compo-cated within the 5 untranslated region. Expansion of
nent of mRNPs, is also found associated with FMRP-the CGG repeats into the mutant range of greater than
containing mRNPs. These data led to the suggestion230 repeats results in hypermethylation and the tran-
that FMRP might target mRNAs to translating ribosomes.scriptional silencing of FMR1. Identification of fragile X
It appears that the I304N mutation, the severe disease-patients with other mutations in FMR1, deletions and a
causing point mutation, alters the structure of mRNPspoint mutation, demonstrate that the absence of a single
and their association with actively translating polyribo-
gene product, FMRP, is the cause of fragile X syndrome
somes. The failure of FMRP with the I304N mutation to
and its associated mental retardation.
associate with the polyribosome has been suggested
For this discussion, it is important to keep in mind to be linked to the inability of this form of FMRP to
that fragile X syndrome is not associated with neurode- dimerize (Feng et al., 1997). From these data, it was
generation. Rather, pathology in the brain of both FRAXA hypothesized that FMRP-containing mRNPs bind a sub-
patients and Fmr1 knockout mice appears to be limited set of mRNAs whose translation is localized to the den-
to the presence of abnormal dendritic spines reminis- drite and is particularly critical for proper synaptic func-
cent of a delay in their maturation (Hinton et al.,1991; tion. While there is some evidence in vitro that FMRP
Comery et al., 1997). may function as a repressor of translation (Li et al., 2001;
FMRP Has RNA Binding Activity Laggerbauer et al., 2001), to what extent and how it
How does the absence of FMRP cause the clinical phe- might effect translation in vivo is unknown. Regardless,
notype seen in fragile X patients? The first insight came in the absence of FMRP, translation of its target mRNAs
from an analysis of the FMRP sequence that revealed would be misregulated (Jin and Warren, 2000).
two types of RNA binding motifs, two ribonucleoprotein Drosophila FMRP and the Synapse
K homology domains, KH domains, and a cluster of The Drosophilia genome contains a single gene that is
arginine and glycine amino acids, an RGG box (Ashley homologous to FMR1, Drosophila fragile X related (dfxr),
et al., 1993; Siomi et al., 1993). The one point mutation also designated dfmr1 (Wan et al., 2000). The dfxr-
allele of FMR1, found in a male with an exceptionally encoded protein (dFXR) contains all of the functional
motifs that have been delineated for FMRP: two KH
domains, one RGG box, an NLS, and an NES. In this1Correspondence: harry@lenti.med.umn.edu
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Table 1. FMRP Target RNAs
Gene G quartet Darnell et al. Brown et al.
Semaphorin 3F   
Potassium channel Kv3.1   
Arginine vasopressin receptor, V1a   
Srm tyrosine kinase   
Histone H4   
Transcription differentiation inhibitor, ID3   
Guanine nucleotide exchange factor   
MAP1B   
Msx2-interacting nuclear protein (Mint)   
GT334/TMEM1   
Munc13 *  
NAP-22 *  
KIAA 1091, Rab6 interacting protein *  
KIAA 0964, PSD-95 associated SAPAP4   
Similar to adenylate cyclase (Hs. 9572) ?  
Similar to MKP-dusPTPase (Hs. 29106)   
TP63   
Casein kinase 1, gamma 2   
Similar to I38022 hypothetical protein ?  
KIAA 0317 protein   
Arg/Abl-interacting protein, ArgBP2   
FMR1 **
* G quartet reported by Brown et al. (2001).
** Schaeffer et al. (2001).
issue of Cell, Zhang and colleagues (2001) use Drosoph- back to genetics, the authors tested further the interac-
tion between dfxr and futsch by creating double mu-ila genetics to demonstrate that dFXR has a role in the
regulation of synapse growth and function, primarily tants. The double-mutant flies with a null mutation in dfxr
and a hypomorphic one in futsch had normal synapticthrough its regulation of the expression of the microtu-
bule-associated protein Futsch. An interesting aspect structure at the NMJ. This strongly suggests dFXR func-
tions to repress futsch translation and that altered regu-of this work is the demonstration that dFXR associates
with futsch mRNA and that dFXR inversely regulates the lation of Futsch is sufficient to explain the effects seen
in the dfxr mutants. To what extent do these results inexpression of Futsch, likely as a translational repressor.
While the effects of altered dFXR expression were Drosophila extend to fragile X syndrome as it manifests
in humans?examined at several sites in the fly nervous system, the
most intriguing results were seen at the neuromuscular FMRP’s Fondness for G Quartets
In the previous issue of Cell (November 16), papers byjunction (NMJ). Null dfxr mutants had a synaptic over-
growth, an enhanced number of synaptic terminals char- Brown et al. (2001) and Darnell et al. (2001) examined
FMRP-associated mRNAs from mammalian brain. Usingacterized by a 50% increase in the number of synaptic
boutons. In contrast, presynaptic overexpression of strategies that combined biochemistry with genomics,
both studies found that FMRP-associated RNAs con-dFXR resulted in an almost 40% reduction in the synap-
tic boutons at the NMJ. Interestingly, postsynaptic over- tained an intramolecular G quartet structure. Previously,
Schaeffer et al. (2001) reported that FMRP binds to itsexpression of dFXR caused a similar but less severe
reduction in the number of synaptic boutons. Thus, in own mRNA via a purine quartet. Using a sequential RNA
selection strategy, Darnell et al. found that FMRP boundthe fly, it seems that dFXR functions to regulate growth
on both sides of the synaptic cleft. Yet, at the physiologi- to sequences having the potential to form a G quartet,
a structure in which four guanine residues are positionedcal level, dFXR modulated neurotransmission by a pre-
synaptic mechanism. Loss of dfxr resulted in an elevated in a planar conformation. These investigators went on
to test whether the formation of a G quartet was criticalneurotransmission and elevated presynaptic overex-
pression of dFXR enhanced spontaneous synaptic vesi- for FMRP binding. By examining binding in the presence
of Li, an inhibitor of G quartet stacking, they found thecle release as measured by a 5-fold increase in the
miniature excitatory junctional currents. binding of the test clone to FMRP was abolished. It was
further shown that the RGG box of FMRP was requiredTaking a cue from the considerable similarity in phe-
notype between the dfxr mutants and futsch hypomorph for binding to the G quartet in the RNA. Brown and
colleagues used mRNA coimmunoprecipitated with mu-mutants, Zhang et al. (2001) examined whether dFXR
might interact with futsch mRNA. They found that futsch rine Fmrp RNPs to probe micorarrays. This resulted in
the identification of 432 mRNAs that were enriched inmRNA could be immunoprecipitated by anti-dFXR anti-
bodies. Moreover, Futsch protein levels in the nervous the Fmrp RNPs. This group also probed micorarrays
using mRNAs isolated from the polyribosome fractionsystem correlated inversely with the level of dfxr expres-
sion. Thus, dFXR seems to function as a repressor of of a human fragile X cell line. This latter probing yielded
251 human mRNAs that had an altered polyribosomeFutsch translation in the nervous system. Returning
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Schaeffer, C., Bardoni, B., Mandel, J.L., Ehresmann, B., Ehresmann,human fragile X cells (Table 1). This work thus identified
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Both in the human and Drosophila, the fragile X protein
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has been found to have a role in synaptic growth. In the Mol. Cell. Biol. 20, 8536–8547.
fly, the data from Zhang et al. strongly indicate that the Zhang, Y.Q., Bailey, A.M., Matthies, H.J.G., Renden, R.B., Smith,
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function. At the very least, these data provide compelling
evidence that dFXR does bind to and regulate the ex-
pression of a specific RNA. How about in mammals?
The identification by Brown et al. and Darnell et al. that
a specific structure, a G quartet, is critical for FMRP to
bind to an mRNA indicates a high level of selectivity.
Thus, in both flies and mammals, FMRP binds preferen-
tially to a subset of RNAs. Since only one RNA, futsch,
was examined for binding to dFXR, the number of fly
mRNAs that are regulated by dFXR remains unknown.
It is important to note that the mammalian homolog of
Futsch, the microtubule associated protein MAP1B, was
identified as a target of murine Fmrp and human FMRP
in Darnell et al. and Brown et al. Thus, it is highly likely,
given the results in Drosophila, that a substantial portion
of the synaptic alterations seen in fragile X patients
results from the misregulation of MAP1B expression,
presumably locally at the synapse. However, the extent
to which alterations in MAP1B expression also underlie
the mental retardation in fragile X syndrome are less
clear. Through a collaborative effort, several mammalian
FMRP RNA targets have been identified (Table 1). One
would certainly like to think that more than one of these
contributes to human cognitive function. It is quite prob-
able that Drosophila will prove useful in their prioriti-
zation.
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